Prodia will raises Rp1.5 trillion from IPO
JAKARTA (TheInsiderStories) – PT Prodia Widyahusada offered 18.75 percent or 20 percent of the enlarged capital and its expecting to raise up to Rp1.5 trillion from the Initial Public Offering (IPO) at the Indonesia Stock Exchange (IDX) in early December.
The companies engaged in the business of health services in particular have clinical laboratory, set the IPO price in the range of Rp 6,250 to Rp 8,000 per share. Prodia has appointed joint lead underwriters PT Indo Premier Securities, PT Credit Suisse Securities Indonesia and PT Citigroup Securities Indonesia.
President Director of Prodia Dewi Muliaty said, most of the IPO proceeds will be used to develop and enlarge the network of outlets the company in Indonesia. The rest will be used for working capital, She added.
Prodia set the offering period on Nov. 30 to Dec. 2 and will list at IDX on Dec. 7, 2016 and will become the first health service company listing at IDX.
Until the first semester 2016, the company scored revenue of Rp 649 billion, up 9.8 percent compared to the same period last year. Meanwhile, total assets reached Rp 591 billion to Rp 100 billion, EBITDA and EBITDA margin of 15.5 percent.
Clinical laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few pharmaceutical educational background lead by Andi Wijaya. Dewi said, Prodia’s network now spread in 30 provinces and plan to open up the network in three provinces again starting 2017.
Source: The Insiderstories